Roche Holding LtdRoche Holding LtdRoche Holding Ltd

Roche Holding Ltd

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪291.15 B‬USD
1.71USD
‪9.40 B‬USD
‪68.69 B‬USD
‪5.52 B‬
Beta (1Y)
0.55

About Roche Holding Ltd


CEO
Thomas Schinecker
Website
Headquarters
Basel
Founded
1896
ISIN
US7711951043
FIGI
BBG000BQYTW3
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Check out other big names from the same industry as RHHBY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
CHGCY3666852
Genentech, Inc. 5.25% 15-JUL-2035
Yield to maturity
5.56%
Maturity date
Jul 15, 2035
CHGCY5317644
Roche Holdings, Inc. 2.607% 13-DEC-2051
Yield to maturity
5.50%
Maturity date
Dec 13, 2051
CHGCY5766486
Roche Holdings, Inc. 5.218% 08-MAR-2054
Yield to maturity
5.48%
Maturity date
Mar 8, 2054
CHGCY5766485
Roche Holdings, Inc. 5.218% 08-MAR-2054
Yield to maturity
5.33%
Maturity date
Mar 8, 2054
CHGCY4184535
Roche Holdings, Inc. 4.0% 28-NOV-2044
Yield to maturity
5.17%
Maturity date
Nov 28, 2044
CHGCY5766483
Roche Holdings, Inc. 4.985% 08-MAR-2034
Yield to maturity
5.15%
Maturity date
Mar 8, 2034
CHGCY5766481
Roche Holdings, Inc. 4.909% 08-MAR-2031
Yield to maturity
5.07%
Maturity date
Mar 8, 2031
CHGCY5766479
Roche Holdings, Inc. 4.79% 08-MAR-2029
Yield to maturity
4.95%
Maturity date
Mar 8, 2029
CHGCY4391962
Roche Holdings, Inc. 7.0% 01-MAR-2039
Yield to maturity
4.91%
Maturity date
Mar 1, 2039
RH0H
Roche Holdings, Inc. 2.625% 15-MAY-2026
Yield to maturity
4.82%
Maturity date
May 15, 2026
CHGCY5766484
Roche Holdings, Inc. 4.985% 08-MAR-2034
Yield to maturity
4.49%
Maturity date
Mar 8, 2034

See all RHHBY bonds 

APIE
ActivePassive International Equity ETF
Weight
1.31%
Market value
‪12.45 M‬
USD
LIFE
Evolve Global Healthcare Enhanced Yield Fund
Weight
5.30%
Market value
‪10.97 M‬
USD
LIFE.B
Evolve Global Healthcare Enhanced Yield Fund
Weight
5.30%
Market value
‪10.97 M‬
USD
INCM
Franklin Income Focus ETF Income Focus ETF
Weight
0.86%
Market value
‪7.61 M‬
USD
LRGC
AB US Large Cap Strategic Equities ETF
Weight
0.69%
Market value
‪4.33 M‬
USD
CANC
Tema Oncology ETF
Weight
4.55%
Market value
‪3.79 M‬
USD
QLTI
GMO International Quality ETF
Weight
3.33%
Market value
‪2.56 M‬
USD
HRTS
Tema Heart & Health ETF
Weight
4.29%
Market value
‪2.24 M‬
USD
SPWO
SP Funds S&P World (ex-US) ETF
Weight
1.51%
Market value
‪1.21 M‬
USD
IDVZ
Opal International Dividend Income ETF
Weight
1.03%
Market value
‪1.08 M‬
USD

Explore more ETFs